Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Science Potential: Biomimicry
View:
Post by forhandlaren on May 16, 2023 9:17am

Science Potential: Biomimicry

From Investor Presentation back in 2015 transformed into text:

Sirona's Glycoprotein program
- - Cosmetic Active Ingredients

- - - - Anti-aging

- - - - Protection & Regeration
- - - - - - Healing / wound care
- - - - - - Hypothermic protection
- - - - - - Sunscreen
- - - - - - Post-sunburn / radiotherapy


- - Adjuvants for biological material preservation

- - - - Cells
- - - - - - Stem cells
- - - - - - Islet cells
- - - - - - Platelets
- - - - - - Red blood cells
- - - - - - Adipocytes

- - - - Tissues
- - - - - - Skin explants
- - - - - - RHE
- - - - - - Cornea

- - - - Organs
- - - - - - Transplant
- - - - - - Renal Reperfusion

- - - - Living organisms
- - - - - - Vaccines


All we need now is that the management impress us with science transformation into very profitable deals. Where is the SGLT2 deals? Anyone?
Comment by Turtle4 on May 16, 2023 10:01am
Management focuses on long-term profit. That is why they did not want a high upfront for 1067 with which they could drive other projects / research. Management would rather do that much much later, when they are profitable. So lets wait some years....
Comment by navajojoe on May 16, 2023 12:09pm
This post has been removed in accordance with Community Policy
Comment by Pandora on May 18, 2023 2:35am
  Sirona Biochem $1,563,600 debenture private placement   2023-05-17 20:27 ET - Private Placement - Debenture   The TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced on March 23, 2023.   Convertible debenture:  $1,563,600 Conversion price:  convertible into units consisting of 15,536 ...more  
Comment by navajojoe on May 18, 2023 8:31am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities